These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 15517612

  • 1. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
    Arlettaz L, Villard J, de Rham C, Degermann S, Chapuis B, Huard B, Roosnek E.
    Eur J Immunol; 2004 Dec; 34(12):3456-64. PubMed ID: 15517612
    [Abstract] [Full Text] [Related]

  • 2. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
    Gunturi A, Berg RE, Crossley E, Murray S, Forman J.
    Eur J Immunol; 2005 Mar; 35(3):766-75. PubMed ID: 15714583
    [Abstract] [Full Text] [Related]

  • 3. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells.
    Gumá M, Busch LK, Salazar-Fontana LI, Bellosillo B, Morte C, García P, López-Botet M.
    Eur J Immunol; 2005 Jul; 35(7):2071-80. PubMed ID: 15940674
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM.
    Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295
    [Abstract] [Full Text] [Related]

  • 5. Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells.
    Kusumi M, Yamashita T, Fujii T, Nagamatsu T, Kozuma S, Taketani Y.
    J Reprod Immunol; 2006 Jun 01; 70(1-2):33-42. PubMed ID: 16488482
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD8 T cells expressing killer Ig-like receptors and NKG2A are present in cord blood and express a more naïve phenotype than their counterparts in adult blood.
    Warren HS, Rana PM, Rieger DT, Hewitt KA, Dahlstrom JE, Kent AL.
    J Leukoc Biol; 2006 Jun 01; 79(6):1252-9. PubMed ID: 16574769
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
    Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE.
    Mol Immunol; 2005 Feb 01; 42(4):485-8. PubMed ID: 15607803
    [Abstract] [Full Text] [Related]

  • 12. Persistent expression of CD94/NKG2 receptors by virus-specific CD8 T cells is initiated by TCR-mediated signals.
    Wojtasiak M, Jones CM, Sullivan LC, Winterhalter AC, Carbone FR, Brooks AG.
    Int Immunol; 2004 Sep 01; 16(9):1333-41. PubMed ID: 15302848
    [Abstract] [Full Text] [Related]

  • 13. NKG2A inhibits NKG2C effector functions of γδ T cells: implications in health and disease.
    Angelini DF, Zambello R, Galandrini R, Diamantini A, Placido R, Micucci F, Poccia F, Semenzato G, Borsellino G, Santoni A, Battistini L.
    J Leukoc Biol; 2011 Jan 01; 89(1):75-84. PubMed ID: 20952657
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses.
    Moser JM, Gibbs J, Jensen PE, Lukacher AE.
    Nat Immunol; 2002 Feb 01; 3(2):189-95. PubMed ID: 11812997
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of the natural killer cell inhibitory receptor CD94/NKG2A and CD158b on circulating and lesional T cells in patients with chronic plaque psoriasis.
    Liao YH, Jee SH, Sheu BC, Huang YL, Tseng MP, Hsu SM, Tsai TF.
    Br J Dermatol; 2006 Aug 01; 155(2):318-24. PubMed ID: 16882169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.